| 000 | 01534 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517081855.0 | ||
| 264 | 0 | _c20170314 | |
| 008 | 201703s 0 0 eng d | ||
| 022 | _a1872-213X | ||
| 024 | 7 |
_a10.2174/1872213x10666160219163502 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPoddighe, Dimitri | |
| 245 | 0 | 0 |
_aSpontaneous (Autoimmune) Chronic Urticaria in Children: Current Evidences, Diagnostic Pitfalls and Therapeutic Management. _h[electronic resource] |
| 260 |
_bRecent patents on inflammation & allergy drug discovery _c2016 |
||
| 300 |
_a34-39 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 |
_aAnti-Allergic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAutoimmune Diseases _xdiagnosis |
| 650 | 0 | 4 |
_aAutoimmunity _xdrug effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aDiagnosis, Differential |
| 650 | 0 | 4 | _aDrug Discovery |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aOmalizumab _xtherapeutic use |
| 650 | 0 | 4 | _aPatents as Topic |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSkin Tests |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUrticaria _xdiagnosis |
| 700 | 1 | _aDe Amici, Mara | |
| 700 | 1 | _aMarseglia, Gian L | |
| 773 | 0 |
_tRecent patents on inflammation & allergy drug discovery _gvol. 10 _gno. 1 _gp. 34-39 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1872213x10666160219163502 _zAvailable from publisher's website |
| 999 |
_c25755144 _d25755144 |
||